A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
Gerstner ER, Ye X, Duda DG, Levine MA, Mikkelsen T, Kaley TJ, Olson JJ, Nabors BL, Ahluwalia MS, Wen PY, Jain RK, Batchelor TT, Grossman S.
Gerstner ER, et al. Among authors: grossman s.
Neuro Oncol. 2015 Oct;17(10):1386-92. doi: 10.1093/neuonc/nov085. Epub 2015 May 24.
Neuro Oncol. 2015.
PMID: 26008604
Free PMC article.
Clinical Trial.